DAB1 and Alzheimer disease: These findings strengthen and extend the concept that ApoER2-Dab1 pathway disruption may be a universal mechanism underlying AD-related degeneration, and suggest that ApoER2-Dab1 disruption in amygdala may contribute to the neuropsychiatric manifestations of AD.